Medications

3-D tumor models improve drug discovery success rate

Imagine millions of cancer cells organized in thousands of small divots. Hit these cells with drugs and when some cells die, you have a candidate for a cancer drug. But a review published this week in the journal Expert Opinion ...

Immunology

Exploring the frontiers of immunity and healing

During a 1989 lecture at the Cold Spring Harbor Symposium on Quantitative Biology, Yale School of Medicine professor Charles Janeway, MD, hypothesized the existence of an innate immune system and special receptors on immune ...

Oncology & Cancer

Cell reprogramming to cure leukaemia and lymphoma

Researchers from the Centre for Genomic Regulation (CRG) in Barcelona reprogramme lymphoma and leukaemia cells to halt their malignancy. Resulting cells remain benign even when no longer subjected to treatment and reduce ...

Medical research

Repurposing finds new uses for old medicines

Medicines that have been approved to medicate one ailment are being repurposed to treat others, saving lives and giving fresh hope to millions saddled with disease.

Oncology & Cancer

Tide is turning in skin cancer battle

A decade ago there was little doctors could do to help a patient with advanced-stage melanoma. Now it seems each week yields important new discoveries about the deadly skin cancer.

page 7 from 9